Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications
Open Access
- 1 January 2016
- journal article
- review article
- Published by Elsevier BV in Advances in Nutrition: An International Review Journal
- Vol. 7 (1), 14-24
- https://doi.org/10.3945/an.115.009803
Abstract
Diabetes is a chronic metabolic disease that affects a substantial part of the population around the world. Whether type I or type II, this disease has serious macro- and microvascular complications that constitute the primary cause of death in diabetic patients. Microvascular complications include diabetic retinopathy, nephropathy, and neuropathy. Although these complications are clinically and etiologically diverse, they share a common factor: glucose-induced damage. In the progression of diabetic complications, oxidative stress, inflammation, and the formation of glycation end products play an important role. Previous studies have shown that a healthy diet is vital in preventing these complications; in particular, the intake of antioxidants has been studied for their potential effect in ameliorating hyperglycemic injuries. Carotenoids are lipid-soluble pigments synthesized by plants, bacteria, and some kinds of algae that are responsible for the yellow, red, and orange colors in food. These compounds are part of the antioxidant machinery in plants and have also shown their efficacy in quenching free radicals, scavenging reactive oxygen species, modulating gene expression, and reducing inflammation in vitro and in vivo, showing that they can potentially be used as part of a preventive strategy for metabolic disorders, including diabetes and its related complications. This review highlights the potential protective effects of 4 non-provitamin A carotenoids—lutein, zeaxanthin, lycopene, and astaxanthin—in the development and progression of diabetic microvascular complications.Keywords
This publication has 109 references indexed in Scilit:
- Astaxanthin Attenuates the Apoptosis of Retinal Ganglion Cells in db/db Mice by Inhibition of Oxidative StressMarine Drugs, 2013
- Inflammation in diabetic retinopathyProgress in Retinal and Eye Research, 2011
- Clinical Trial of Lutein in Patients With Retinitis Pigmentosa Receiving Vitamin AJAMA Ophthalmology, 2010
- Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetesDiabetologia, 2010
- p38MAPK: stress responses from molecular mechanisms to therapeuticsTrends in Molecular Medicine, 2009
- Are the health attributes of lycopene related to its antioxidant function?Archives of Biochemistry and Biophysics, 2009
- Associations Between Age-Related Nuclear Cataract and Lutein and Zeaxanthin in the Diet and Serum in the Carotenoids in the Age-Related Eye Disease Study (CAREDS), an Ancillary Study of the Women's Health InitiativeAmerican Journal of Ophthalmology, 2008
- Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cellsExperimental Eye Research, 2008
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003